Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1214674

Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti


G, Leksic; M, Baretic; L, Gudelj; M, Radic; M, Ivanisevic
Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti // Endocrine Abstracts
Zagreb, Hrvatska: BioScientifica, 2022. str. 1-2 doi:10.1530/endoabs.83.domno3 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 1214674 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti
(Type 1 diabetes mellitus in pregnancy: high incidence of large-for- gestational-age neonates despite adequate glycemic control and low glycemic variability)

Autori
G, Leksic ; M, Baretic ; L, Gudelj ; M, Radic ; M, Ivanisevic

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Endocrine Abstracts / - : BioScientifica, 2022, 1-2

Skup
9th ESE Young Endocrinologists and Scientists Meeting 2022 (EYES)

Mjesto i datum
Zagreb, Hrvatska, 02.09.2022. - 04.09.2022

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
šećerna bolest tip 1, trudnoća, novorođenčad velika za gestacijsku dob
(type 1 diabetes mellitus, pregnancy, large-for-gestational-age neonates)

Sažetak
Background Pregnancy with type 1 diabetes mellitus (T1DM) carries risks for many adverse outcomes ; the most common are large-for-gestational-age neonates (LGA). Proper glycemic control reduces the risk for LGA. However, it occurs in almost 40% of T1DM pregnancies despite of achieving almost normoglycemia. Some studies suggested the contributing role of maternal body mass index (BMI) and glucovariability, but the effect on development of LGA still remains unclear. Objectives The aim of this study was to analyse incidence of LGA in planned and well- controlled T1DM pregnancies. Methods This prospective study included 42 patients with T1DM who were using continuous glucose monitoring (CGM) from preconception to delivery. Including criteria were preconception counselling, CGM at least 3 months prior to the study, duration of T1DM for at least 1 year, HbA1c ! 7.5%, BMI !25 kg/m2. Excluding criteria were HbA1c O7.5% and maternal weight gain O 20 kg in the 2nd and 3rd trimester. Patients used intermittently scanned CGM and data was analysed once in every trimester. Statistical analysis was performed with IBM SPSS software and data was defined as mean and standard deviation. Results In the first, second and third trimester time in range was 54.3G14.3, 62.4G 10.6, 67.5G11.7% respectively. Glucose management indicator was 6.5G0.5, 6.0G 0.4, 5.9G0.4% and %coefficient of variation 41.2G7.5, 38.6G5.9, 34.1G6.5% in the first, second and third trimester, respectively. Neonatal birth weight was 3594.3G632.2 grams, birth weight percentile 72.1G28.6 and 45% of neonates were LGA. Conclusions In this study we observed improved glycaemic control and decrease of glycemic variability from the first to the third trimester as a result of structured preconception counselling and strict follow-up. However, there was high incidence of LGA despite adequate glycemic control, low glycemic variability and normal BMI. Further studies for defining LGA aetiology in T1DM pregnancies are needed.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb

Profili:

Avatar Url Marina Ivanišević (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

G, Leksic; M, Baretic; L, Gudelj; M, Radic; M, Ivanisevic
Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti // Endocrine Abstracts
Zagreb, Hrvatska: BioScientifica, 2022. str. 1-2 doi:10.1530/endoabs.83.domno3 (predavanje, međunarodna recenzija, sažetak, znanstveni)
G, L., M, B., L, G., M, R. & M, I. (2022) Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti. U: Endocrine Abstracts doi:10.1530/endoabs.83.domno3.
@article{article, author = {G, Leksic and M, Baretic and L, Gudelj and M, Radic and M, Ivanisevic}, year = {2022}, pages = {1-2}, DOI = {10.1530/endoabs.83.domno3}, keywords = {\v{s}e\'{c}erna bolest tip 1, trudno\'{c}a, novoro\djen\v{c}ad velika za gestacijsku dob}, doi = {10.1530/endoabs.83.domno3}, title = {\v{S}e\'{c}erna bolest tip 1 u trudno\'{c}i: visoka incidencija novoro\djen\v{c}adi velike za gestacijsku dob unato\v{c} adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti}, keyword = {\v{s}e\'{c}erna bolest tip 1, trudno\'{c}a, novoro\djen\v{c}ad velika za gestacijsku dob}, publisher = {BioScientifica}, publisherplace = {Zagreb, Hrvatska} }
@article{article, author = {G, Leksic and M, Baretic and L, Gudelj and M, Radic and M, Ivanisevic}, year = {2022}, pages = {1-2}, DOI = {10.1530/endoabs.83.domno3}, keywords = {type 1 diabetes mellitus, pregnancy, large-for-gestational-age neonates}, doi = {10.1530/endoabs.83.domno3}, title = {Type 1 diabetes mellitus in pregnancy: high incidence of large-for- gestational-age neonates despite adequate glycemic control and low glycemic variability}, keyword = {type 1 diabetes mellitus, pregnancy, large-for-gestational-age neonates}, publisher = {BioScientifica}, publisherplace = {Zagreb, Hrvatska} }

Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font